Beijing, Nov. 12, 2021——InnoCare Pharma (HKEX: 09969), a leading biotech company,announced today that the company executives will attend the upcoming investor conferences organized by Goldman Sachs and Morgan Stanley to share company’s latest development. Details are as follows:
Goldman Sachs Asia Pacific Healthcare Forum 2021
Panel Discussion: 13:45-14:30, Beijing time, Nov. 15, 2021 (Monday)
Morgan Stanley 20th Virtual Asia Pacific Summit
Panel Discussion: 14:00-14:50, Beijing time, Nov. 17, 2021 (Wednesday)
Investors who have interest can contact the organizers to join the above meetings and InnoCare looks forward to having in-depth discussions with investors. InnoCare also welcomes investors to contact for meeting arrangements if needed.
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong, New Jersey and Boston.